Preparation of Thermosensitive Gel for Controlled Release of Levofloxacin and Their Application in the Treatment of Multidrug-Resistant Bacteria.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27689094)

Published in Biomed Res Int on September 05, 2016

Authors

Danilo Antonini Alves1, Daisy Machado1, Adriana Melo1, Rafaella Fabiana Carneiro Pereira1, Patrícia Severino2, Luciana Maria de Hollanda3, Daniele Ribeiro Araújo4, Marcelo Lancellotti5

Author Affiliations

1: Laboratory of Biotechnology (LABIOTEC), Institute of Biology, University of Campinas (UNICAMP), Campinas, SP, Brazil.
2: Laboratory of Nanotechnology and Nanomedicine (LNMed), Institute of Technology and Research (ITP), Aracaju, SE, Brazil; Tiradentes University (UNIT), Aracaju, SE, Brazil.
3: Tiradentes University (UNIT), Aracaju, SE, Brazil.
4: Center of Natural Sciences and Humanities, Federal University of ABC (UFABC), Santo André, SP, Brazil.
5: Laboratory of Biotechnology (LABIOTEC), Institute of Biology, University of Campinas (UNICAMP), Campinas, SP, Brazil; Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil.

Associated clinical trials:

Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis | NCT03472144

Articles cited by this

Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35

1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS. J Med Pharm Chem (1962) 13.97

A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res (2000) 5.88

Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. Chem Rev (2005) 2.70

Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J (2007) 2.38

Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm (2007) 2.25

A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res (2006) 2.22

Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res (1972) 2.01

Injectable hydrogels as unique biomedical materials. Chem Soc Rev (2008) 1.97

The quinolones: past, present, and future. Clin Infect Dis (2005) 1.48

Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy (2001) 1.45

Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front Microbiol (2013) 1.42

From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev (2008) 1.35

Mechanism of quinolone action and resistance. Biochemistry (2014) 1.34

Multidrug evolutionary strategies to reverse antibiotic resistance. Science (2016) 1.31

Mode of action of fluoroquinolones. Drugs (1999) 1.27

The quinolones: decades of development and use. J Antimicrob Chemother (2003) 1.20

Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol (2000) 1.16

Sustained release of lidocaine from Poloxamer 407 gels. Int J Pharm (2004) 1.16

Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int (2013) 1.05

Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection. Drugs (2008) 1.04

Onset of analgesia with sodium ibuprofen, ibuprofen acid incorporating poloxamer and acetaminophen--a single-dose, double-blind, placebo-controlled study in patients with post-operative dental pain. Eur J Clin Pharmacol (2009) 0.95

Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them. Microb Pathog (2016) 0.94

Controlled release injectable liposomal gel of ibuprofen for epidural analgesia. Int J Pharm (2000) 0.92

Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge. Biochem Soc Trans (2012) 0.91

Antibiotic resistance mechanisms of clinically important bacteria. Medicina (Kaunas) (2011) 0.91

Effect of sodium chloride on the release, absorption and safety of diclofenac sodium delivered by poloxamer gel. Int J Pharm (2003) 0.90

Nanocarriers. Pharm Res (2007) 0.90

Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels. Eur J Pharm Sci (2002) 0.88

Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm Res (1995) 0.87

Injectable microparticle-gel system for prolonged and localized lidocaine release. I. In vitro characterization. J Biomed Mater Res A (2004) 0.87

Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels. J Control Release (1998) 0.86

Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188. Int J Clin Pharmacol Ther (2010) 0.86

Bioadhesive films containing benzocaine: correlation between in vitro permeation and in vivo local anesthetic effect. Pharm Res (2010) 0.85

Clinical features and management of adverse effects of quinolone antibacterials. Drug Saf (1991) 0.84

The ins and outs of RND efflux pumps in Escherichia coli. Front Microbiol (2015) 0.84

Injectable microparticle-gel system for prolonged and localized lidocaine release. II. In vivo anesthetic effects. J Biomed Mater Res A (2004) 0.83

Long-lasting infiltration anaesthesia by lidocaine-loaded biodegradable nanoparticles in hydrogel in rats. Acta Anaesthesiol Scand (2009) 0.81

Thermoresponsive hydrogels in biomedical applications: A seven-year update. Eur J Pharm Biopharm (2015) 0.80

Micellization and gelation of mixed copolymers P123 and F127 in aqueous solution. Langmuir (2007) 0.80

Graphene and carbon nanotube nanocomposite for gene transfection. Mater Sci Eng C Mater Biol Appl (2014) 0.79

Poloxamer-based binary hydrogels for delivering tramadol hydrochloride: sol-gel transition studies, dissolution-release kinetics, in vitro toxicity, and pharmacological evaluation. Int J Nanomedicine (2015) 0.79

The 4-quinolone antibiotics: past, present, and future. Pharmacotherapy (1988) 0.78

Structure, rheology and shear alignment of Pluronic block copolymer mixtures. J Colloid Interface Sci (2008) 0.78

Irradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivo. PLoS One (2013) 0.78

Preparation of levofloxacin thermo-sensitive gel and clinical application in the treatment of suppurative otitis media. Acta Otolaryngol (2014) 0.78

First global report on antimicrobial resistance released by the WHO. Natl Med J India (2015) 0.78

Boron nitride nanotubes chemically functionalized with glycol chitosan for gene transfection in eukaryotic cell lines. J Biomed Mater Res A (2014) 0.78

Controlling the gelation of aqueous micellar solutions of ethylene-oxide-based block copoly(oxyalkylene)s. Int J Pharm (2005) 0.78

Micelles and gels of mixed triblock copoly(oxyalkylene)s in aqueous solution. Langmuir (2005) 0.77

Carbon nanoparticles for gene transfection in eukaryotic cell lines. Mater Sci Eng C Mater Biol Appl (2014) 0.77

Pluronics f-127/l-81 binary hydrogels as drug-delivery systems: influence of physicochemical aspects on release kinetics and cytotoxicity. Langmuir (2014) 0.77

Triggered-release nanocapsules for drug delivery to the lungs. Nanomedicine (2014) 0.77

Sol-gel synthesis, structure and bioactivity of polycaprolactone/CaO . SiO2 hybrid material. J Mater Sci Mater Med (2004) 0.76

Characterization of smart auto-degradative hydrogel matrix containing alginate lyase to enhance levofloxacin delivery against bacterial biofilms. Int J Pharm (2015) 0.76

Blue-gray pigmentation in trunk and extremities in a 71-year-old man. JAMA Dermatol (2013) 0.76

Size dependence of molecular self-assembling in stacked aggregates. 1. NMR investigation of ciprofloxacin self-association. J Phys Chem B (2012) 0.76

Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: Antibiotic resistance tests and HaCat and NIH/3T3 cell viability studies. Colloids Surf B Biointerfaces (2015) 0.76